NCT00457613
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +16 more
- Locations
-
- Radboud University Medical Centre Nijmegen, Gelderland, Netherlands
Clinical trial condition
Explore clinical trials studying Shock. Study availability and eligibility vary by location and protocol.
NCT00457613
NCT00122707
NCT00046072